Our Approach to Holding Drug Companies Responsible On October 6, 2023, Siskinds LLP filed a proposed GLP-1 drug class action in the Supreme Court of British Columbia against Novo Nordisk and affiliated entities on behalf of persons in Canada who were prescribed and used Ozempic, Rybelsus, and/or Wegovy and suffered serious injuries
Foundayo (Orforglipron) The innovative Foundayo weight loss pill, approved in April 2026, offers unmatched flexibility among oral GLP-1s
The post says this biochemical separation suggests they may not directly compete, but stops short of calling the pairing safe by default
Lorigooini Z, Sadeghi Dehsahraei K, Bijad E, Habibian Dehkordi S, Amini-Khoei H
This is why supplements are commonly preferred
These best practices maintain the preservatives effectiveness